News

ASA

News about ASA: events, facts and developments on tafs uz.

1 stories

Voy's at-home testosterone test ads banned for misleading claims

The UK Advertising Standards Authority (ASA) banned five advertisements from the online healthcare provider Voy concerning at-home testosterone tests. The regulator concluded that the ads misleadingly linked common symptoms—such as irritability, fatigue, reduced libido, and mood swings—to low testosterone without sufficient evidence, despite these symptoms having multiple possible causes. One Facebook ad claimed that 'low testosterone silently affects one in four men over 30', which the ASA found unsubstantiated. This marks the third such ruling in recent months, following similar actions against BioID Health and Numan Digital Healthcare in August. The ASA emphasized that while advertising for such tests is allowed, claims must be accurate and evidence-based. Voy stated it removed the ads during the investigation and will not repeat them, maintaining that its campaigns were designed to reduce stigma around men's health discussions. Medical experts caution that low testosterone levels can be easily influenced by factors like time of day, recent meals, illness, or lack of sleep, and that age-related declines alone rarely cause significant health issues.

3 min read